WASHINGTON (AP) — The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19. Antibody drugs from Regeneron and Eli Lilly have been the go-to drugs to keep patients out of the hospital. But the drugmakers have warned that their infused medications are far less potent against the latest variant. A third drug from GlaxoSmithKline appears more effective. But it’s not widely available in the U.S. For now, federal officials are stockpiling doses for use in coming weeks. Experts predict omicron could dominate the U.S. outbreak by early next year.
![Virus Outbreak California](https://ewscripps.brightspotcdn.com/dims4/default/5cd704b/2147483647/strip/true/crop/3840x2160+0+200/resize/1280x720!/quality/90/?url=https%3A%2F%2Fewscripps.brightspotcdn.com%2Fdf%2F67%2F9cdb072f4a9f885b634256c8257b%2Fap21332810247644.jpg)
Jae C. Hong/AP
FILE - A medical staff member prepares the Pfizer COVID-19 vaccine at Tudor Ranch in Mecca, Calif., on Jan. 21, 2021. In a statement Sunday, Nov. 28, 2021, California's public health officer, Dr. Tomas J. Aragon, said that officials are monitoring the Omicron variant. There are no reports to date of the variant in California, the statement said. Aragon said the state was focusing on ensuring its residents have access to vaccines and booster shots. (AP Photo/Jae C. Hong, File)
![Virus Outbreak California](https://ewscripps.brightspotcdn.com/dims4/default/5cd704b/2147483647/strip/true/crop/3840x2160+0+200/resize/1280x720!/quality/90/?url=https%3A%2F%2Fewscripps.brightspotcdn.com%2Fdf%2F67%2F9cdb072f4a9f885b634256c8257b%2Fap21332810247644.jpg)
Posted
and last updated
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.